Ì첩ÌåÓý

A 2023 study suggests that eating more red meat—about a one additional serving each day—is linked to a higher risk of developing diabetes than those who eat less.

A 2023 study of 1.5 million people found that those who had uncontrolled high blood pressure or diabetes prior to getting COVID-19 had increased risks for COVID complications (such as hospitalization or being on a ventilator), compared with people whose high blood pressure or diabetes was well controlled.

In a 2023 Harvard Medical School study of more than 216,000 people (followed for up to 36 years), those who reported eating the most red meat had a 62% higher risk of developing diabetes, compared with those who reported eating the least red meat each week.

Skin tags are fleshy, soft growths that tend to develop on the neck, under the arms, or around the groin. People who develop many skin tags should see their doctor, since they may be associated with diabetes or metabolic syndrome. Skin tags can be removed using various methods.

According to a 2023 study, a person's waist-to-hip ratio—the circumference of the waist divided by the circumference of the hip—is a better predictor of future health issues like high blood pressure, heart disease, and type 2 diabetes than body mass index.

Food products advertised as being lower in sugar or sugar-free contain sugar substitutes. Sugar alcohol is another ingredient used as a sweetener in food products. But is sugar alcohol a better choice nutritionally than other sweeteners or natural sugar?

Even slightly elevated blood sugar levels—a condition known as pre-diabetes—may raise the risk of cardiovascular problems. But attention to weight loss and greater use of medications to lower blood pressure and cholesterol appear to reduce the risk.

A newer class of medications used to treat type 2 diabetes called glucagon-like peptide-1 (GLP-1) receptor agonists has gained attention because of their impressive weight-loss results—in many cases, 10% to 20% of a person's body weight. Versions of two of these GLP-1 receptor agonists, liraglutide (Saxenda) and semaglutide (Wegovy), are FDA-approved for weight loss, even for people without diabetes. However, there isn't enough evidence to know whether these drugs might be beneficial or dangerous for people who are not diagnosed with diabetes or obesity.

People who get most of their recommended weekly physical activity over one or two days may lower their heart disease risk just as much as those who are active more regularly throughout the week. Evidence also suggests there's no particular benefit to exercising at certain times of the day, including with respect to mealtimes. So people should be physically active whenever they find it to be most convenient.

Approximately 88 million Americans—more than one in three—have prediabetes, a condition in which the average amount of sugar in the blood (glucose) is high but not high enough to be diagnosed as diabetes. Among people who develop prediabetes, older ones are less likely than younger ones to eventually develop full-blown diabetes. Still, they should have their glucose levels checked, as prediabetes can put them at high risk for heart attack and stroke.